SEC Filing Summary for Ming Hsieh - Fulgent Genetics, Inc.

Ming Hsieh, CEO of Fulgent Genetics, Inc. (FLGT), reported a transaction on May 26, 2026. The filing indicates the withholding of 2,949 shares of Common Stock to satisfy tax obligations arising from the vesting of restricted stock units. The transaction price was $17.67 per share, resulting in 897,685 shares remaining post-transaction. The filing also details various indirect holdings, including shares held by The Ming Hsieh Trust (7,895,115 shares), the Dynasty Trust (220,816 shares), a Uniform Transfer to Minor Account (1,000 shares), and by an immediate family member (1,000 shares). Mr. Hsieh, as CEO and a 10% owner, has direct and indirect influence over these holdings, acting as trustee for the Hsieh Trust and custodian for the UTMA account.